XML 26 R13.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-Based Compensation
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The following table summarizes the expense recognized within general and administrative expenses in the Unaudited Consolidated Statements of Income related to stock-based compensation for the three and six months ended June 30, 2026 and 2025 (in thousands):
 
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Stock options$7,686 $6,955 $15,667 $12,269 
Restricted stock24,328 21,913 43,842 34,965 
Stock-based compensation$32,014 $28,868 $59,509 $47,234 
The tax benefits recorded on stock-based compensation, inclusive of the tax benefits upon the exercises of options and vesting of restricted stock were $22.6 million and $25.9 million for the six months ended June 30, 2026 and 2025, respectively.
The following table summarizes the Company’s total unrecognized compensation cost related to outstanding stock awards as of June 30, 2026 (cost in thousands):
Unrecognized
Compensation
Cost
Weighted Average
Period of Expense
Recognition Remaining
(in Years)
Stock options$51,883 1.75
Restricted stock64,679 0.99
Total$116,562 
Stock Options
The following summarizes the changes in the number of shares of stock options outstanding for the six months ended June 30, 2026 (shares and aggregate intrinsic value in thousands):
SharesWeighted
Average
Exercise
Price		Options
Exercisable
at End of
Period		Weighted
Average
Exercise
Price of
Exercisable
Options		Weighted
Average Fair
Value of
Options
Granted 
During the Period		Aggregate
Intrinsic
Value
Outstanding at December 31, 20252,593 $227.70 1,551 $185.93 $206,036 
Granted186 332.93 $101.62 
Exercised(452)191.27 $71,562 
Forfeited(17)328.46 
Outstanding at June 30, 20262,310 $242.57 1,283 $195.08 $213,897 
Expected to vest as of June 30, 2026
1,027 $301.85 
The aggregate intrinsic value of stock options exercisable at June 30, 2026 was $178.6 million. The weighted average remaining contractual term of options exercisable at June 30, 2026 was 2.7 years.
Restricted Stock
The following table summarizes the changes in the number of shares of restricted stock awards and restricted stock units outstanding for the six months ended June 30, 2026 (shares in thousands):
 
SharesWeighted
Average
Grant Date
Fair Value
Outstanding at December 31, 2025343 $304.83 
Granted240 324.18 
Cancelled
(19)330.21 
Issued
(241)303.41 
Outstanding at June 30, 2026323 $318.75